openPR Logo
Press release

Full-process Services of Eukaryotic Microbial 18S Sequencing at Creative Biogene

08-02-2022 09:00 AM CET | Health & Medicine

Press release from: Creative Biogene

Microbialtec Lab is one of the main business units in Creative Biogene, which is dedicated to offering full-process services of eukaryotic microbial 18S sequencing from DNA extraction to PCR amplification, purification, sequencing, and analysis of eukaryotic microbes.

18S ribosomal RNA is a structural RNA for the small element of eukaryotic cytoplasmic ribosomes. Owing to its high specificity and sequence conservation, the 18S rRNA gene has been regarded as the most commonly used marker for exploring the community structure of eukaryotic protists in aquatic and terrestrial environments. For example, the 18S rDNA gene can be utilized for the identification and molecular systematics of eukaryotic microorganisms such as microalgae and protozoa.

For over a decade, Creative Biogene has been focused on microbiological research and is now capable of providing 18S rRNA gene sequencing services to help researchers identify, classify, and quantify microbes within complex biological mixtures. Clients can choose different service packages featured with wide applicability, cost-efficiency, and high speed according to their project needs.

To simplify clients' 18S rRNA identification process, the company releases 3 service packages covering sequence amplification of 18S rRNA, sequencing of PCR products, cloning of related genes, and sequencing alignment analysis within a 1-2 weeks turnaround time. In addition, the expert team can also construct gene libraries of eukaryotic microbial 18S rDNA and develop RFLP makers within 5-6 weeks to provide a full analysis of eukaryotic microbial community diversity.

"Our 16S/18S/ITS amplicon sequencing is supportive of identifying and investigating the microbial community. With over 10 years of experience, we can meet your project requirements and budgets in the exploration of microbial biodiversity and optimize your biological and therapeutic research. We have advanced sequencing platforms and a diverse range of one-stop eukaryotic microbial 18S sequencing services to enable comprehensive bioinformatic analysis and in-depth microbiological studies," the marketing manager at Creative Biogene said.

Creative Biogene
New York, USA
Marcia Brady
+1 631 386 8241

About Creative Biogene
Creative Biogene aims to provide the latest strategies of high-level microbiological research services to pharmaceutical researchers and industrial partners all over the world. With years of experience, the company is capable of offering customers an overall microbiological research program, including sample collection, preservation methods, preliminary experiments and impact evaluation, experiments and data analysis, etc. Creative Biogene is dedicated to assisting researchers in exploring the hidden mysteries between microbes and health, production, and the environment to better use microbial resources.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Full-process Services of Eukaryotic Microbial 18S Sequencing at Creative Biogene here

News-ID: 2695034 • Views:

More Releases from Creative Biogene

Full-Scale Mitochondrial Bioenergetics Services at Creative Biogene
As one of the leading bio-companies engaged in mitochondrial research, Creative Biogene, together with its large team of experts, creates a powerful mitochondrial research service platform. To satisfy the research needs of global customers on mitochondrial bioenergies, Creative Biogene provides partners with a comprehensive range of mitochondrial bioenergetics detection and analysis services based on years of experience and high-end instruments. Mitochondria are the primary source of ATP for most cells
Genetically Steady and Cost-effective Gene Knockout Stable Cell Lines Products at Creative Biogene
Genetically Steady and Cost-effective Gene Knockout Stable Cell Lines Products a …
Creative Biogene creatively develops a series of genetically steady and cost-effective gene knockout stable cell lines products for domestic and overseas clients. New York, United States - December 02, 2021—With years of experience in the gene-engineering field, Creative Biogene has built a team of experts to perform genome editing with CRISPR/Cas9 technology, from designing gRNA to transfection and single clone generation. After rigorous and copious experiments and tests, Creative Biogene can
Creative Biogene Offers One-Stop Customized CRISPR Based Microbe Genome Editing …
Creative Biogene Offers One-Stop Customized CRISPR Based Microbe Genome Editing Service for global clients. New York, United States - August 18, 2021—Creative Biogene has been dedicated itself to undertaking the cause of bioscience for decades and enjoys rich experiences and expertise in CRISPR gene-editing areas. Through years of efforts and competitive advantages, its CRISPR-based microbe genome editing service is rather renowned at home and abroad. CRISPR/Cas9 platform, which is a mature and
CRISPR/Cas9 Platform: One Stop Custom Knock-in Cell Line Generation Service
CRISPR/Cas9 Platform, the major division of Creative Biogene, is committed to applying CRISPR/Cas9 technology in different fields with comprehensive gene editing services and products, including gene knockout, gene knockin and point mutation. One of the new launched service is the one stop custom knock-in cell line generation service which can be applied in the field of gene editing. The CRISPR/Cas9 platform provides customized knock-in cell line generation services, including point mutation

All 5 Releases


More Releases for RNA

CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes. CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032. This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - • 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate? • The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%. • Expected exponential
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032. The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may